Cobra Biologics Is Now Part of Charles River

Cobra Biologics

In April 2021, Charles River acquired Cognate BioServices, which included Cobra Biologics, a leading international contract development and manufacturing organization (CDMO) specializing in premium plasmid DNA and viral vector services to support the Advanced Therapy Medicinal Products (ATMP) industry. Cobra and Cognate, alongside Vigene Biosciences, join Charles River to offer customers a single, trusted partner who has the insight and experience to take your cell and gene therapy products from bench to bedside.

Connect With an Advanced Therapies Specialist

 

Explore Our Cell and Gene Therapy CDMO Solutions

Stay Connected

Stay connected through this exciting transition by joining our mailing list. Sign up to keep in touch with our industry-leading scientists and receive news about our world-class products and services.

Sign up